
1. j med chem. 2014 jan 9;57(1):29-41. doi: 10.1021/jm400633d. epub 2013 dec 23.

optimization furin inhibitors protect activation influenza
hemagglutinin h5 shiga toxin.

gagnon h(1), beauchemin s, kwiatkowska a, couture f, d'anjou f, levesque c,
dufour f, desbiens ar, vaillancourt r, bernard s, desjardins r, malouin f, dory
yl, day r.

author information: 
(1)institut de pharmacologie de sherbrooke (ips) département de
chirurgie/urologie, faculté de médecine et des sciences de la santé (fmss),
université de sherbrooke , 3001, 12e avenue nord, sherbrooke, québec j1h 5n4,
canada.

proprotein convertases (pcs) crucial processing entry viral 
bacterial protein precursors confer increased infectivity pathogens
bearing pc activation site, results increased symptom severity and
lethality. previously, developed nanomolar peptide inhibitor pcs to
prevent pc activation infectious agents. herein, describe peptidomimetic 
approach increases stability inhibitor use vivo to
prevent systemic infections cellular damage, caused influenza
h5n1 shiga toxin. addition azaβ(3)-amino acids termini 
peptide successfully prevented influenza hemagglutinin 5 fusogenicity shiga
toxin vero toxicity cell-based assays. results cell-based model
using stable shrna-induced proprotein convertase knockdown indicate only
furin major proprotein convertase required ha5 cleavage.

doi: 10.1021/jm400633d 
pmid: 24359257  [indexed medline]

